(Q55090683)

English

HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab.

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab. (English)

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

clear cell adenocarcinoma

1 reference

based on heuristic

inferred from title

ovarian clear cell adenocarcinoma

1 reference

based on heuristic

inferred from title

8

object named as

Shigeru Saito

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

Noriyuki Katsumata

2

object named as

Noriyuki Katsumata

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

author name string

Masaki Fujimura

1

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

Hiroshi Tsuda

3

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

Naoko Uchi

4

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

Satomi Miyazaki

5

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

Takao Hidaka

6

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

Masatoshi Sakai

7

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

publication date

1 November 2002

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

93

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

1250-1257

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

11

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

HER-2/neu amplification and overexpression in endometrial carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Selection of human ovarian carcinoma cells with high dissemination potential by repeated passage of the cells in vivo into nude mice, and involvement of Le(x)-determinant in the dissemination potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Estrogens, the immune response and autoimmunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

p185neu expression in human lung adenocarcinomas predicts shortened survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

19 June 2018

The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

13 August 2018

Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

13 August 2018

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926901

13 August 2018

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification and over-expression of theEGFR anderbB-2 genes in human esophageal adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endometrioid and clear cell carcinoma of the ovary. Factors affecting survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12460467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.2002.TB01231.X

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

release_g7h6xlyrb5fajouw4uh7twzg7e

1 reference

https://api.fatcat.wiki/v0/release/g7h6xlyrb5fajouw4uh7twzg7e

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

1 reference

Europe PubMed Central

18 June 2018

http://europepmc.org/abstract/PMC/5926901

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55090683&oldid=2118536663"